A Study of RPL554 Drug Administered by Metered Dose Inhaler to Treat Chronic Obstructive Pulmonary Disease
Clinical trial NCT04091360 · COMPLETED
Trial details
- NCT number
- NCT04091360
- Sponsor
- Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-29
- Primary completion
- 2020-12-10
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.